These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 9627096)

  • 1. Distinct functional characteristics of levocabastine sensitive rat neurotensin NT2 receptor expressed in Chinese hamster ovary cells.
    Yamada M; Yamada M; Lombet A; Forgez P; Rostène W
    Life Sci; 1998; 62(23):PL 375-80. PubMed ID: 9627096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurotensin is an antagonist of the human neurotensin NT2 receptor expressed in Chinese hamster ovary cells.
    Vita N; Oury-Donat F; Chalon P; Guillemot M; Kaghad M; Bachy A; Thurneyssen O; Garcia S; Poinot-Chazel C; Casellas P; Keane P; Le Fur G; Maffrand JP; Soubrie P; Caput D; Ferrara P
    Eur J Pharmacol; 1998 Nov; 360(2-3):265-72. PubMed ID: 9851594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential ontogenetic patterns of levocabastine-sensitive neurotensin NT2 receptors and of NT1 receptors in the rat brain revealed by in situ hybridization.
    Lépée-Lorgeoux I; Betancur C; Rostène W; Pélaprat D
    Brain Res Dev Brain Res; 1999 Mar; 113(1-2):115-31. PubMed ID: 10064881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-affinity neurotensin receptor (NTS2) signaling: internalization-dependent activation of extracellular signal-regulated kinases 1/2.
    Gendron L; Perron A; Payet MD; Gallo-Payet N; Sarret P; Beaudet A
    Mol Pharmacol; 2004 Dec; 66(6):1421-30. PubMed ID: 15361549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of rapid desensitization of Ca2+ responses in transfected CHO cells expressing the rat neurotensin receptor despite agonist-induced internalization.
    Hermans E; Gailly P; Gillis JM; Octave JN; Maloteaux JM
    J Neurochem; 1995 Jun; 64(6):2518-25. PubMed ID: 7760031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacology and functional properties of NTS2 neurotensin receptors in cerebellar granule cells.
    Sarret P; Gendron L; Kilian P; Nguyen HM; Gallo-Payet N; Payet MD; Beaudet A
    J Biol Chem; 2002 Sep; 277(39):36233-43. PubMed ID: 12084713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of beta-lactotensin, a bioactive peptide derived from bovine beta-lactoglobulin, as a neurotensin agonist.
    Yamauchi R; Usui H; Yunden J; Takenaka Y; Tani F; Yoshikawa M
    Biosci Biotechnol Biochem; 2003 Apr; 67(4):940-3. PubMed ID: 12784648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of neurotensin-induced pancreatic carcinoma growth by a nonpeptide neurotensin receptor antagonist, SR48692.
    Iwase K; Evers BM; Hellmich MR; Kim HJ; Higashide S; Gully D; Thompson JC; Townsend CM
    Cancer; 1997 May; 79(9):1787-93. PubMed ID: 9128997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of binding sites of a new neurotensin receptor antagonist, [3H]SR 142948A, in the rat brain.
    Betancur C; Canton M; Burgos A; Labeeuw B; Gully D; Rostène W; Pélaprat D
    Eur J Pharmacol; 1998 Feb; 343(1):67-77. PubMed ID: 9551716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of SR 48692 on neurotensin-induced calcium-activated chloride currents in the Xenopus oocyte expression system: agonist-like activity on the levocabastine-sensitive neurotensin receptor and absence of antagonist effect on the levocabastine insensitive neurotensin receptor.
    Botto JM; Guillemare E; Vincent JP; Mazella J
    Neurosci Lett; 1997 Feb; 223(3):193-6. PubMed ID: 9080465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Agonist properties of a stable hexapeptide analog of neurotensin, N alpha MeArg-Lys-Pro-Trp-tLeu-Leu (NT1).
    Akunne HC; Demattos SB; Whetzel SZ; Wustrow DJ; Davis DM; Wise LD; Cody WL; Pugsley TA; Heffner TG
    Biochem Pharmacol; 1995 Apr; 49(8):1147-54. PubMed ID: 7748196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The partial agonist properties of levocabastine in neurotensin-induced analgesia.
    Dubuc I; Remande S; Costentin J
    Eur J Pharmacol; 1999 Sep; 381(1):9-12. PubMed ID: 10528128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Agonism, inverse agonism, and neutral antagonism at the constitutively active human neurotensin receptor 2.
    Richard F; Barroso S; Martinez J; Labbé-Jullié C; Kitabgi P
    Mol Pharmacol; 2001 Dec; 60(6):1392-8. PubMed ID: 11723247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization and autoradiographic localization of neurotensin binding sites in human sigmoid colon.
    Azriel Y; Burcher E
    J Pharmacol Exp Ther; 2001 Jun; 297(3):1074-81. PubMed ID: 11356931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of DARPP-32 Thr75 phosphorylation by neurotensin in neostriatal neurons: involvement of glutamate signalling.
    Matsuyama S; Fukui R; Higashi H; Nishi A
    Eur J Neurosci; 2003 Sep; 18(5):1247-53. PubMed ID: 12956723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of the neurotensin receptor antagonist SR48692 on rat blood pressure modulation by neurotensin.
    Gully D; Lespy L; Canton M; Rostène W; Kitabgi P; Le Fur G; Maffrand JP
    Life Sci; 1996; 58(8):665-74. PubMed ID: 8594316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Receptor mediated internalization of neurotensin in transfected Chinese hamster ovary cells.
    Hermans E; Octave JN; Maloteaux JM
    Biochem Pharmacol; 1994 Jan; 47(1):89-91. PubMed ID: 8311847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical and pharmacological profile of a potent and selective nonpeptide antagonist of the neurotensin receptor.
    Gully D; Canton M; Boigegrain R; Jeanjean F; Molimard JC; Poncelet M; Gueudet C; Heaulme M; Leyris R; Brouard A
    Proc Natl Acad Sci U S A; 1993 Jan; 90(1):65-9. PubMed ID: 8380498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurotensin inhibits background K+ channels and facilitates glutamatergic transmission in rat spinal cord dorsal horn.
    Kadiri N; Rodeau JL; Schlichter R; Hugel S
    Eur J Neurosci; 2011 Oct; 34(8):1230-40. PubMed ID: 21936876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pretreatment with SR48692 has different effects on central neurotensin-induced gastric mucosal defense and inhibition of gastric acid secretion in rats.
    Karinch AM; Schmidt GL; Kauffman GL
    Brain Res; 1998 Nov; 810(1-2):123-9. PubMed ID: 9813278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.